FdaApplication
NDA 022465
Identifiers
- fda_app_no: NDA022465
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2009-10-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VOTRIENT | PAZOPANIB HYDROCHLORIDE | EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| VOTRIENT | PAZOPANIB HYDROCHLORIDE | EQ 200MG BASE | TABLET;ORAL |
2 products